Drug Industry Critic Tapped For FDA Seat
A long-standing opponent of the pharmaceutical industry has reportedly been appointed to a four-year term on a committee that advises the U.S. Food and Drug Administration on drug safety issues, a...To view the full article, register now.
Already a subscriber? Click here to view full article